Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Viticks
- Development stage
- Unknown
- Lead developer
- Henning Arzneimittel
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Viticks is a topical insect repellent spray developed and marketed by HENNIG ARZNEIMITTEL. The product's active ingredient is icaridin (also known as picaridin) at a concentration of 15%. Unlike insecticides that kill insects, Viticks functions as a repellent by creating a protective scent barrier on the skin or clothing that deters blood-sucking insects. It is designed to provide protection against a wide range of insects, including mosquitoes (such as malaria, yellow fever, and tiger mosquitoes), ticks, horseflies, and grass mites. Viticks offers protection lasting up to 8 hours against mosquitoes and horseflies, and up to 6 hours against ticks. The spray features a 360-degree application system and is approved for use in adults and children aged 2 years and older.
- Brand names
- Viticks
Beyond the preview
Go deeper on Viticks.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Viticks.